Cargando…
The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822625/ https://www.ncbi.nlm.nih.gov/pubmed/29466979 http://dx.doi.org/10.1186/s12933-018-0674-3 |
_version_ | 1783301727663947776 |
---|---|
author | Darsalia, Vladimer Larsson, Martin Klein, Thomas Patrone, Cesare |
author_facet | Darsalia, Vladimer Larsson, Martin Klein, Thomas Patrone, Cesare |
author_sort | Darsalia, Vladimer |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5822625 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58226252018-02-26 The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors Darsalia, Vladimer Larsson, Martin Klein, Thomas Patrone, Cesare Cardiovasc Diabetol Commentary BioMed Central 2018-02-21 /pmc/articles/PMC5822625/ /pubmed/29466979 http://dx.doi.org/10.1186/s12933-018-0674-3 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Darsalia, Vladimer Larsson, Martin Klein, Thomas Patrone, Cesare The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors |
title | The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors |
title_full | The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors |
title_fullStr | The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors |
title_full_unstemmed | The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors |
title_short | The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors |
title_sort | high need for trials assessing functional outcome after stroke rather than stroke prevention with glp-1 agonists and dpp-4 inhibitors |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822625/ https://www.ncbi.nlm.nih.gov/pubmed/29466979 http://dx.doi.org/10.1186/s12933-018-0674-3 |
work_keys_str_mv | AT darsaliavladimer thehighneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors AT larssonmartin thehighneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors AT kleinthomas thehighneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors AT patronecesare thehighneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors AT darsaliavladimer highneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors AT larssonmartin highneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors AT kleinthomas highneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors AT patronecesare highneedfortrialsassessingfunctionaloutcomeafterstrokeratherthanstrokepreventionwithglp1agonistsanddpp4inhibitors |